Clinical Trials Logo

Clinical Trial Summary

Aim: To describe the duration of desaturation and bradypnea in postoperative opioid-naïve and chronic opioid patients. Patients: 691 patients included from two previous WARD (Wireless Assessment of Respiratory and circulatory Distress) projects. Outcome: Respiratory deviations four hours after opioid administration


Clinical Trial Description

Aim: To describe the duration of desaturation and bradypnea in postoperative opioid-naïve and chronic opioid patients within the first four hours following opioid administration in addition to the chronic dose, using a continuously wireless monitoring system. Patients: 691 patients included from two previous WARD (Wireless Assessment of Respiratory and circulatory Distress) projects. Continuous wireless monitoring data of peripheral tissue oxygenation (SpO2) and respiratory rate (RR) was conducted in postoperative patients. Data were stratified into opioid-naïve and chronic opioid patients, based on their preoperative opioid history. Patients who did not receive opioids postoperatively were served as the control group. Data was evaluated one hour before and four hours after opioid administration. The primary outcome was the cumulative duration of SpO2 <88%. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06227208
Study type Observational
Source Rigshospitalet, Denmark
Contact
Status Completed
Phase
Start date October 1, 2023
Completion date January 16, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT06106516 - Vital Sign Monitor Device Validation - WARD
Terminated NCT03637296 - Adapting Critical Time Intervention to Support Inpatient Medical Care Transition N/A